Bryan Slepicka, DO
Pain Medicine · Mountain Home, ARNPI 1487115358
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Boston Scientific at 37.9% of the total. 2025 is the largest year on record at $4,590, 2.5 times the $1,827 reported in 2023.
Across 60 payments — averaging $144.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Saluda Medical Americas, Inc.$2K
- Nevro Corp.$2K
- SPR Therapeutics, Inc$613
- Abbott$303
- Medtronic$138
- plus $312 from 6 others
What the payments were for
- Travel & lodging$4,29550%
- Food & beverage$3,24537%
- Education$1,13513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $3,284 |
| Saluda Medical Americas, Inc. | 14 | $2,213 |
| Nevro Corp. | 5 | $1,812 |
| SPR Therapeutics, Inc | 6 | $613 |
| Abbott | 3 | $303 |
| Medtronic | 1 | $138 |
| Curonix LLC | 1 | $91 |
| Globus Medical | 3 | $78 |
| Convatec Inc. | 1 | $63 |
| AbbVie | 3 | $45 |
| Braeburn Inc. | 1 | $20 |
| Edwards Lifesciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,801
- Senza$1,735
- GENERAL - THERAPIES$1,596
- SPRINT PNS System$472
- PROCLAIM$198
- Superion Indirect Decompression System$182
- INTELLIS ADAPTIVESTIM$138
- Intracept$126
How this compares
$8,675 in reported general payments places this provider in the 75th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $1,845 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $475 |
| Gabapentin | 36 | $345 |
| Methocarbamol | 25 | $324 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $320 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $303 |
| Pregabalin | 20 | $253 |
| Oxycodone Hcl | 18 | $246 |
| Celecoxib | 17 | $205 |
| Tramadol Hcl | 17 | $158 |
| Diclofenac Sodium | 12 | $133 |
| Meloxicam | 35 | $82 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Mountain Home
- Maria Lyuksyutova-PriceMountain Home$19K
- Matthew McNelleyMountain Home$5K
- Ira ChatmanMountain Home$2K
- Stephen PaulusLittle Rock$75K
- Mark MiedemaFayetteville$35K
- George ArcosConway$30K
- George DeimelFayetteville$26K
- Julio OlayaLittle Rock$22K
- Daniel JudkinsConway$17K
- Sheffield KentConway$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.